Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.
Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.
The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
Media Articles Related to Meprobamate
Anxiety Doubles Cancer Mortality in Men, but Not Women
Source: Medscape Psychiatry & Mental Health Headlines [2016.09.21]
A diagnosis of generalized anxiety disorder is associated with a significant increase in cancer mortality risk in men but, oddly, not in women, new research shows.
Medscape Medical News
Anxiety - a risk factor for death from cancer in men
Source: Anxiety / Stress News From Medical News Today [2016.09.21]
Men who suffer from anxiety are more than twice as likely to die from cancer as men who don't.
Scientists discover response to anxiety linked to movement control areas in brain
Source: Anxiety / Stress News From Medical News Today [2016.09.19]
Researchers have discovered that the response to anxiety in teenagers may include not only the parts of the brain which deal with emotions (the limbic system), as has been long understood, but also...
Source: MedicineNet Suicide Specialty [2016.08.24]
Title: Separation Anxiety
Category: Diseases and Conditions
Created: 10/10/2002 12:00:00 AM
Last Editorial Review: 8/24/2016 12:00:00 AM
Post-transplant anxiety linked to complex instructions, caregiver empathy
Source: Anxiety / Stress News From Medical News Today [2016.08.19]
Some anxiety is perfectly normal for kidney transplant patients, but new research suggests that medical staff can help patients feel more at ease when they leave the hospital and that could...
Published Studies Related to Meprobamate
Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).
Reports of Suspected Meprobamate Side Effects
Toxicity TO Various Agents (28),
Respiratory Arrest (15),
Cardiac Arrest (15),
Accidental Death (14),
Drug Abuse (11),
Completed Suicide (11),
Multiple Drug Overdose Accidental (5),
Pulmonary Congestion (5),
Pulmonary Oedema (4), more >>
Page last updated: 2016-09-21